Kulkarni Samarth bought ORKA
June 2, 2026 · Form 4 insider transaction
Kulkarni Samarth bought 9,136 shares of Oruka Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
9,136
Price
$0.00
Total value
N/A
InsiderKulkarni Samarth
RoleOfficer, Director
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 2, 2026
Filing dateJune 3, 2026
Shares owned after9,136
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests as to 1/12 of the underlying shares monthly from June 2, 2026.